{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:46:16Z","timestamp":1793400376189,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","award":["U54AG062333"],"award-info":[{"award-number":["U54AG062333"]}],"id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapies are often used for the treatment, remission, and possible cure of autoimmune diseases, infectious diseases, and cancers. Empirical evidence illustrates that females and males differ in outcomes following the use of biologics for the treatment of autoimmune diseases, e.g., rheumatoid arthritis (RA), infectious diseases, e.g., influenza, and solid tumor cancers. Females tend to experience more adverse reactions than males following the use of a class of biologics referred to as immunotherapies. For immunotherapies aimed at stimulating an immune response, e.g., influenza vaccines, females develop greater responses and may experience greater efficacy than males. In contrast, for immunotherapies that repress an immune response, e.g., tumor necrosis factor (TNF) inhibitors for RA or checkpoint inhibitors for melanoma, the efficacy is reportedly greater for males than females. Despite these differences, discrepancies in reporting differences between females and males exist, with females have been historically excluded from biomedical and clinical studies. There is a critical need for research that addresses the biological (i.e., sex) as well as sociocultural (i.e., gender) causes of male-female disparities in immunotherapy responses, toxicities, and outcomes. One-size-fits-all approaches to immunotherapies will not work, and sex\/gender may contribute to variable treatment success, including adherence, in clinical settings.<\/jats:p>","DOI":"10.1186\/s13293-020-00301-y","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T07:02:57Z","timestamp":1588575777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":189,"title":["The impact of sex and gender on immunotherapy outcomes"],"prefix":"10.1186","volume":"11","author":[{"given":"Sabra L.","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"301_CR1","unstructured":"Naqvi S, Godfrey AK, Hughes JF, Goodheart ML, Mitchell RN, Page DC: Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science 2019, 365(6450)."},{"key":"301_CR2","unstructured":"Wizemann TM, Pardue, M. (ed.): Exploring the biological contributions to human health: does sex matter? Washington DC: National Academy Press; 2001."},{"key":"301_CR3","unstructured":"Guidelines FG: General considerations for the clinical evaluation of drugs. In.; 1977."},{"issue":"4","key":"301_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1586\/ecp.11.29","volume":"4","author":"A Parekh","year":"2011","unstructured":"Parekh A, Fadiran EO, Uhl K, Throckmorton DC. Adverse effects in women: implications for drug development and regulatory policies. Expert review of clinical pharmacology. 2011;4(4):453\u201366.","journal-title":"Expert review of clinical pharmacology"},{"issue":"9","key":"301_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00001888-199409000-00003","volume":"69","author":"VW Pinn","year":"1994","unstructured":"Pinn VW. The role of the NIH's office of research on women's health. Academic medicine : journal of the Association of American Medical Colleges. 1994;69(9):698\u2013702.","journal-title":"Academic medicine : journal of the Association of American Medical Colleges"},{"issue":"3","key":"301_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neubiorev.2010.07.002","volume":"35","author":"AK Beery","year":"2011","unstructured":"Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011;35(3):565\u201372.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5728","key":"301_CR7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1126\/science.1115616","volume":"308","author":"V Simon","year":"2005","unstructured":"Simon V. Wanted: women in clinical trials. Science. 2005;308(5728):1517.","journal-title":"Science"},{"issue":"10171","key":"301_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(18)32995-7","volume":"393","author":"CR Sugimoto","year":"2019","unstructured":"Sugimoto CR, Ahn YY, Smith E, Macaluso B, Lariviere V. Factors affecting sex-related reporting in medical research: a cross-disciplinary bibliometric analysis. Lancet. 2019;393(10171):550\u20139.","journal-title":"Lancet"},{"issue":"26","key":"301_CR9","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1200\/JCO.2018.78.3290","volume":"36","author":"BC Ozdemir","year":"2018","unstructured":"Ozdemir BC, Csajka C, Dotto GP, Wagner AD. Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018;36(26):2680\u20133.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"301_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/ana.1134","volume":"50","author":"DB Carter","year":"2001","unstructured":"Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. Ann Neurol. 2001;50(4):468\u201375.","journal-title":"Ann Neurol"},{"key":"301_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fphar.2019.00047","volume":"10","author":"B Lagana","year":"2019","unstructured":"Lagana B, Zullo A, Scribano ML, Chimenti MS, Migliore A, Picchianti Diamanti A, Lorenzetti R, Scolieri P, Ridola L, Ortona E, et al. Sex differences in response to TNF-inhibiting drugs in patients with spondyloarthropathies or inflammatory bowel diseases. Front Pharmacol. 2019;10:47.","journal-title":"Front Pharmacol"},{"key":"301_CR12","first-page":"465898","volume":"2010","author":"LJ Zhu","year":"2010","unstructured":"Zhu LJ, Yang X, Yu XQ. Anti-TNF-alpha therapies in systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010:465898.","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"301_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12016-007-8005-6","volume":"32","author":"JM Meijer","year":"2007","unstructured":"Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG. The future of biologic agents in the treatment of Sjogren's syndrome. Clin Rev Allergy Immunol. 2007;32(3):292\u20137.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"301_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/rheumatology\/ker250","volume":"51","author":"K Jayakumar","year":"2012","unstructured":"Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, Prouse P, Young A. Early Rheumatoid Arthritis S: Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology (Oxford). 2012;51(1):169\u201375.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"301_CR15","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/acr.21762","volume":"64","author":"D Jawaheer","year":"2012","unstructured":"Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, Khanna D, Greenberg JD, Furst DE. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2012;64(12):1811\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"301_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/jrheum.110548","volume":"39","author":"D Jawaheer","year":"2012","unstructured":"Jawaheer D, Olsen J, Hetland ML. Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry. J Rheumatol. 2012;39(1):46\u201353.","journal-title":"J Rheumatol"},{"issue":"1","key":"301_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/ard.2006.056937","volume":"66","author":"K Forslind","year":"2007","unstructured":"Forslind K, Hafstrom I, Ahlmen M, Svensson B, Group BS. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis. 2007;66(1):46\u201352.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"301_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","volume":"45","author":"KL Hyrich","year":"2006","unstructured":"Hyrich KL, Watson KD, Silman AJ, Symmons DP. British Society for Rheumatology Biologics R: Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006;45(12):1558\u201365.","journal-title":"Rheumatology (Oxford)"},{"key":"301_CR19","doi-asserted-by":"crossref","unstructured":"Hambardzumyan K, Hermanrud C, Marits P, Vivar N, Ernestam S, Wallman JK, van Vollenhoven RF, Fogdell-Hahn A. Saevarsdottir S, group Ss: Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population. Scand J Rheumatol. 2019:1\u20135.","DOI":"10.1080\/03009742.2019.1602670"},{"issue":"10","key":"301_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00296-014-2999-x","volume":"34","author":"J Lee","year":"2014","unstructured":"Lee J, Mason R, Martin L, Barnabe C. Biologic therapy response and drug survival for females compared to males with rheumatoid arthritis: a cohort study. Rheumatol Int. 2014;34(10):1449\u201353.","journal-title":"Rheumatol Int"},{"issue":"8","key":"301_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00296-016-3448-9","volume":"36","author":"N Gossen","year":"2016","unstructured":"Gossen N, Jacob L, Kostev K. Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis. Rheumatol Int. 2016;36(8):1113\u20138.","journal-title":"Rheumatol Int"},{"issue":"10","key":"301_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/acr.20258","volume":"62","author":"LE Kristensen","year":"2010","unstructured":"Kristensen LE, Karlsson JA, Englund M, Petersson IF, Saxne T, Geborek P. Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register. Arthritis Care Res (Hoboken). 2010;62(10):1362\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"301_CR23","first-page":"523","volume":"55","author":"A Souto","year":"2016","unstructured":"Souto A, Maneiro JR, Gomez-Reino JJ. Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases. Rheumatology (Oxford). 2016;55(3):523\u201334.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"301_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20(6):35.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"301_CR25","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/rheumatology\/key140","volume":"57","author":"P Hojgaard","year":"2018","unstructured":"Hojgaard P, Ballegaard C, Cordtz R, Zobbe K, Clausen M, Glintborg B, Kristensen LE, Dreyer L. Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish health care registers. Rheumatology (Oxford). 2018;57(9):1651\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"301_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/1756-185X.13271","volume":"21","author":"T Rusman","year":"2018","unstructured":"Rusman T, Ten Wolde S, Euser SM, van der Ploeg T, van Hall O, van der Horst-Bruinsma IE. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice. Int J Rheum Dis. 2018;21(4):836\u201342.","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"301_CR27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1172\/JCI78082","volume":"125","author":"K Rubtsova","year":"2015","unstructured":"Rubtsova K, Marrack P, Rubtsov AV. Sexual dimorphism in autoimmunity. J Clin Invest. 2015;125(6):2187\u201393.","journal-title":"J Clin Invest"},{"issue":"5","key":"301_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"37","key":"301_CR29","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1016\/j.vaccine.2013.06.039","volume":"31","author":"C Pulcini","year":"2013","unstructured":"Pulcini C, Massin S, Launay O, Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. Vaccine. 2013;31(37):3943\u20139.","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"301_CR30","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1093\/infdis\/jiu066","volume":"209","author":"SL Klein","year":"2014","unstructured":"Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209(Suppl 3):S114\u20139.","journal-title":"J Infect Dis"},{"issue":"30","key":"301_CR31","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1016\/j.vaccine.2009.04.029","volume":"27","author":"MM Endrich","year":"2009","unstructured":"Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009;27(30):4018\u201324.","journal-title":"Vaccine"},{"issue":"7","key":"301_CR32","first-page":"PH92","volume":"15","author":"RM Merrill","year":"2009","unstructured":"Merrill RM, Beard JD. Influenza vaccination in the United States, 2005-2007. Med Sci Monit. 2009;15(7):PH92\u2013100.","journal-title":"Med Sci Monit"},{"issue":"38","key":"301_CR33","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1016\/j.vaccine.2010.07.029","volume":"28","author":"R Jimenez-Garcia","year":"2010","unstructured":"Jimenez-Garcia R, Hernandez-Barrera V, de Andres AL, Jimenez-Trujillo I, Esteban-Hernandez J, Carrasco-Garrido P. Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995-2006). Vaccine. 2010;28(38):6169\u201375.","journal-title":"Vaccine"},{"key":"301_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","volume":"33","author":"KL Flanagan","year":"2017","unstructured":"Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33:577\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"22","key":"301_CR35","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","volume":"168","author":"RJ Engler","year":"2008","unstructured":"Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008;168(22):2405\u201314.","journal-title":"Arch Intern Med"},{"issue":"2","key":"301_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1073\/pnas.1321060111","volume":"111","author":"D Furman","year":"2014","unstructured":"Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014;111(2):869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"301_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","volume":"4","author":"T Potluri","year":"2019","unstructured":"Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29.","journal-title":"NPJ Vaccines"},{"issue":"7","key":"301_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4161\/hv.8476","volume":"5","author":"IF Cook","year":"2009","unstructured":"Cook IF. Sex differences in injection site reactions with human vaccines. Human Vaccines. 2009;5(7):441\u20139.","journal-title":"Human Vaccines"},{"issue":"4","key":"301_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/clinids\/5.4.737","volume":"5","author":"TR Cate","year":"1983","unstructured":"Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis. 1983;5(4):737\u201347.","journal-title":"Rev Infect Dis"},{"issue":"14","key":"301_CR40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/archinte.1996.00440130090009","volume":"156","author":"KL Nichol","year":"1996","unstructured":"Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med. 1996;156(14):1546\u201350.","journal-title":"Arch Intern Med"},{"issue":"2","key":"301_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7883\/yoken.65.99","volume":"65","author":"JH Kim","year":"2012","unstructured":"Kim JH, Cho HY, Hennessey KA, Lee HJ, Bae GR, Kim HC. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea. Japanese journal of infectious diseases. 2012;65(2):99\u2013104.","journal-title":"Japanese journal of infectious diseases"},{"issue":"2","key":"301_CR42","first-page":"107","volume":"26","author":"JI Marques","year":"2013","unstructured":"Marques JI, Ribeiro Vaz I, Santos C, Polonia J. Adverse events with the influenza A(H1N1) vaccine Pandemrix(R) at healthcare professionals in Portugal. Acta medica portuguesa. 2013;26(2):107\u201312.","journal-title":"Acta medica portuguesa"},{"issue":"5","key":"301_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1054\/jpai.2001.24551","volume":"2","author":"ME Robinson","year":"2001","unstructured":"Robinson ME, Riley JL 3rd, Myers CD, Papas RK, Wise EA, Waxenberg LB, Fillingim RB. Gender role expectations of pain: relationship to sex differences in pain. J Pain. 2001;2(5):251\u20137.","journal-title":"J Pain"},{"issue":"6","key":"301_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1084\/jem.20182395","volume":"216","author":"JM Fritz","year":"2019","unstructured":"Fritz JM, Lenardo MJ. Development of immune checkpoint therapy for cancer. J Exp Med. 2019;216(6):1244\u201354.","journal-title":"J Exp Med"},{"issue":"4","key":"301_CR45","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","volume":"18","author":"MB Cook","year":"2009","unstructured":"Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174\u201382.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"301_CR46","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"301_CR47","unstructured":"WHO: The health and well-being of men in the WHO European Region: better health through a gender approach. In. Edited by Europe WHOROf; 2018."},{"issue":"59","key":"301_CR48","doi-asserted-by":"publisher","first-page":"99336","DOI":"10.18632\/oncotarget.22242","volume":"8","author":"A Botticelli","year":"2017","unstructured":"Botticelli A, Onesti CE, Zizzari I, Cerbelli B, Sciattella P, Occhipinti M, Roberto M, Di Pietro F, Bonifacino A, Ghidini M, et al. The sexist behaviour of immune checkpoint inhibitors in cancer therapy? Oncotarget. 2017;8(59):99336\u201346.","journal-title":"Oncotarget"},{"issue":"1","key":"301_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ijc.31301","volume":"143","author":"Y Wu","year":"2018","unstructured":"Wu Y, Ju Q, Jia K, Yu J, Shi H, Wu H, Jiang M. Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors). Int J Cancer. 2018;143(1):45\u201351.","journal-title":"Int J Cancer"},{"issue":"58","key":"301_CR50","doi-asserted-by":"publisher","first-page":"31167","DOI":"10.18632\/oncotarget.25795","volume":"9","author":"F Conforti","year":"2018","unstructured":"Conforti F, Pala L, Goldhirsch A. Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system. Oncotarget. 2018;9(58):31167\u20138.","journal-title":"Oncotarget"},{"key":"301_CR51","doi-asserted-by":"crossref","unstructured":"Grassadonia A, Sperduti I, Vici P, Iezzi L, Brocco D, Gamucci T, Pizzuti L, Maugeri-Sacca M, Marchetti P, Cognetti G et al: Effect of gender on the outcome of patients receiving immune checkpoint inhibitors for advanced cancer: a systematic review and meta-analysis of phase III randomized clinical trials. J Clin Med 2018, 7(12).","DOI":"10.3390\/jcm7120542"},{"issue":"10","key":"301_CR52","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","volume":"28","author":"L Khoja","year":"2017","unstructured":"Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review. Ann Oncol. 2017;28(10):2377\u201385.","journal-title":"Ann Oncol"},{"issue":"4","key":"301_CR53","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/annonc\/mdx818","volume":"29","author":"BC Ozdemir","year":"2018","unstructured":"Ozdemir BC, Coukos G, Wagner AD. Immune-related adverse events of immune checkpoint inhibitors and the impact of sex-what we know and what we need to learn. Ann Oncol. 2018;29(4):1067.","journal-title":"Ann Oncol"},{"issue":"5780","key":"301_CR54","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1126\/science.1124978","volume":"312","author":"P Pisitkun","year":"2006","unstructured":"Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312(5780):1669\u201372.","journal-title":"Science"},{"key":"301_CR55","volume-title":"Tang WY","author":"AL Fink","year":"2018","unstructured":"Fink AL, Engle K, Ursin RL. Tang WY. Biological sex affects vaccine efficacy and protection against influenza in mice. Proc Natl Acad Sci U S A: Klein SL; 2018."},{"key":"301_CR56","doi-asserted-by":"crossref","unstructured":"Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, Pienkowski C, Chaumeil J, Mej\u00eda J, Gu\u00e9ry J-C: TLR7 escapes X chromosome inactivation in immune cells. Science Immunology 2018, 3:eaap8855.","DOI":"10.1126\/sciimmunol.aap8855"},{"issue":"4","key":"301_CR57","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.4049\/jimmunol.177.4.2088","volume":"177","author":"B Berghofer","year":"2006","unstructured":"Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006;177(4):2088\u201396.","journal-title":"J Immunol"},{"issue":"11","key":"301_CR58","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","volume":"195","author":"M Griesbeck","year":"2015","unstructured":"Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, Sharei A, Kourjian G, Porichis F, Hart M, et al. Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-alpha production in women. J Immunol. 2015;195(11):5327\u201336.","journal-title":"J Immunol"},{"issue":"3","key":"301_CR59","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1095\/biolreprod.107.063545","volume":"78","author":"JA Rettew","year":"2008","unstructured":"Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008;78(3):432\u20137.","journal-title":"Biol Reprod"},{"issue":"1","key":"301_CR60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T","volume":"46","author":"G Moxley","year":"2002","unstructured":"Moxley G, Posthuma D, Carlson P, Estrada E, Han J, Benson LL, Neale MC. Sexual dimorphism in innate immunity. Arthritis Rheum. 2002;46(1):250\u20138.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"301_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00024382-200116050-00003","volume":"16","author":"K Asai","year":"2001","unstructured":"Asai K, Hiki N, Mimura Y, Ogawa T, Unou K, Kaminishi M. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock. 2001;16(5):340\u20133.","journal-title":"Shock"},{"issue":"1","key":"301_CR62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbrc.2013.10.042","volume":"441","author":"M Aomatsu","year":"2013","unstructured":"Aomatsu M, Kato T, Kasahara E, Kitagawa S. Gender difference in tumor necrosis factor-alpha production in human neutrophils stimulated by lipopolysaccharide and interferon-gamma. Biochem Biophys Res Commun. 2013;441(1):220\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"301_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-02155-8","volume-title":"Roberts CW (eds.): Sex hormones and immunity to infection","author":"SL Klein","year":"2010","unstructured":"Klein SL. Roberts CW (eds.): Sex hormones and immunity to infection. Berlin: Springer Verlag; 2010."},{"issue":"5094","key":"301_CR64","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/2141224a0","volume":"214","author":"M Butterworth","year":"1967","unstructured":"Butterworth M, McClellan B, Allansmith M. Influence of sex in immunoglobulin levels. Nature. 1967;214(5094):1224\u20135.","journal-title":"Nature"},{"issue":"29-30","key":"301_CR65","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","volume":"26","author":"IF Cook","year":"2008","unstructured":"Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008;26(29-30):3551\u20135.","journal-title":"Vaccine"},{"key":"301_CR66","first-page":"814598","volume":"2014","author":"H Fan","year":"2014","unstructured":"Fan H, Dong G, Zhao G, Liu F, Yao G, Zhu Y, Hou Y. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. Journal of immunology research. 2014;2014:814598.","journal-title":"Journal of immunology research"},{"issue":"5","key":"301_CR67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10522-008-9138-6","volume":"9","author":"A Wikby","year":"2008","unstructured":"Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100\u2009years of age. Biogerontology. 2008;9(5):299\u2013308.","journal-title":"Biogerontology"},{"issue":"5","key":"301_CR68","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.humimm.2004.02.021","volume":"65","author":"MC Villacres","year":"2004","unstructured":"Villacres MC, Longmate J, Auge C, Diamond DJ. Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol. 2004;65(5):476\u201385.","journal-title":"Hum Immunol"},{"issue":"12","key":"301_CR69","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm1295-1279","volume":"1","author":"A Amadori","year":"1995","unstructured":"Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4\/CD8 T-cell ratio in humans. Nat Med. 1995;1(12):1279\u201383.","journal-title":"Nat Med"},{"issue":"10","key":"301_CR70","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4103\/0019-5359.42725","volume":"62","author":"BR Das","year":"2008","unstructured":"Das BR, Bhanushali AA, Khadapkar R, Jeswani KD, Bhavsar M, Dasgupta A. Reference ranges for lymphocyte subsets in adults from western India: influence of sex, age and method of enumeration. Indian J Med Sci. 2008;62(10):397\u2013406.","journal-title":"Indian J Med Sci"},{"key":"301_CR71","volume-title":"Strickland FM","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Patel D, Yarlagadda S. Strickland FM. Stronger inflammatory\/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun: Richardson BC; 2009."},{"issue":"10","key":"301_CR72","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"301_CR73","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","volume":"10","author":"C Libert","year":"2010","unstructured":"Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10(8):594\u2013604.","journal-title":"Nat Rev Immunol"},{"key":"301_CR74","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.intimp.2019.04.048","volume":"72","author":"AH Schneider","year":"2019","unstructured":"Schneider AH, Kanashiro A, Dutra SGV, Souza RDN, Veras FP, Cunha FQ, Ulloa L, Mecawi AS, Reis LC, Malvar DDC. Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice. Int Immunopharmacol. 2019;72:504\u201310.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"301_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13685538.2018.1482487","volume":"22","author":"NV Mohamad","year":"2019","unstructured":"Mohamad NV, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S, Chin KY. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019;22(2):129\u201340.","journal-title":"Aging Male"},{"issue":"1","key":"301_CR76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20080521","volume":"206","author":"S Pauklin","year":"2009","unstructured":"Pauklin S, Sernandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK. Estrogen directly activates AID transcription and function. J Exp Med. 2009;206(1):99\u2013111.","journal-title":"J Exp Med"},{"issue":"5","key":"301_CR77","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.4049\/jimmunol.0803205","volume":"182","author":"C Wang","year":"2009","unstructured":"Wang C, Dehghani B, Li Y, Kaler LJ, Proctor T, Vandenbark AA, Offner H. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J Immunol. 2009;182(5):3294\u2013303.","journal-title":"J Immunol"},{"issue":"2","key":"301_CR78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jnr.20881","volume":"84","author":"MJ Polanczyk","year":"2006","unstructured":"Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res. 2006;84(2):370\u20138.","journal-title":"J Neurosci Res"},{"issue":"10189","key":"301_CR79","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/S0140-6736(19)30652-X","volume":"393","author":"L Heise","year":"2019","unstructured":"Heise L, Greene ME, Opper N, Stavropoulou M, Harper C, Nascimento M, Zewdie D, Gender Equality N, Health Steering C. Gender inequality and restrictive gender norms: framing the challenges to health. Lancet. 2019;393(10189):2440\u201354.","journal-title":"Lancet"},{"issue":"6","key":"301_CR80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00128071-200102060-00001","volume":"2","author":"M Rademaker","year":"2001","unstructured":"Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol. 2001;2(6):349\u201351.","journal-title":"Am J Clin Dermatol"},{"key":"301_CR81","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.2147\/DDDT.S97088","volume":"10","author":"D Colombo","year":"2016","unstructured":"Colombo D, Zagni E, Nica M, Rizzoli S, Ori A, Bellia G. Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis. Drug Des Devel Ther. 2016;10:2917\u201327.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"301_CR82","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/bcp.13923","volume":"85","author":"ST de Vries","year":"2019","unstructured":"de Vries ST, Denig P, Ekhart C, Burgers JS, Kleefstra N, Mol PGM, van Puijenbroek EP. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: an explorative observational study. Br J Clin Pharmacol. 2019;85(7):1507\u201315.","journal-title":"Br J Clin Pharmacol"},{"key":"301_CR83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"301_CR84","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/02813432.2016.1207141","volume":"34","author":"JT Jorgensen","year":"2016","unstructured":"Jorgensen JT, Andersen JS, Tjonneland A, Andersen ZJ. Determinants related to gender differences in general practice utilization: Danish diet, cancer and health cohort. Scand J Prim Health Care. 2016;34(3):240\u20139.","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"301_CR85","first-page":"147","volume":"49","author":"KD Bertakis","year":"2000","unstructured":"Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147\u201352.","journal-title":"J Fam Pract"},{"issue":"4","key":"301_CR86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169(4):205\u201313.","journal-title":"Ann Intern Med"},{"issue":"9","key":"301_CR87","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/jan.12361","volume":"70","author":"SL Chen","year":"2014","unstructured":"Chen SL, Lee WL, Liang T, Liao IC. Factors associated with gender differences in medication adherence: a longitudinal study. J Adv Nurs. 2014;70(9):2031\u201340.","journal-title":"J Adv Nurs"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-020-00301-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T19:20:15Z","timestamp":1666466415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-020-00301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1186\/s13293-020-00301-y","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"17 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}